The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinomaP. Economopoulou, A. Psyrri, Anastasios Kyriazoglou et al.|ESMO Open|2025Cited by 4
962P Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC)Θεόδωρος Ράμπιας, A. Psyrri, Niki Gavrielatou et al.|Annals of Oncology|2020Cited by 0